🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Trastuzumab Injectable Product

Found 94 matching trials

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

PHASE3

This is a randomized, double-blind, multicenter trial，parallel control desi...

Status

Completed

Location

Fudan University Cancer Hospital

Start Date

2020-11-23

Trial ID

NCT04629846

Treatments Being Tested

Trastuzumab QL1209 Pertuzumab Docetaxel surgery

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

PHASE3

This is a Phase IIIb, multinational, multicenter, randomized, open-label st...

Status

Completed

Location

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Start Date

2022-07-05

Trial ID

NCT05415215

Treatments Being Tested

Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)Pertuzumab IV Trastuzumab IV Trastuzumab Emtansine Investigator's Choice of Chemotherapy Surgery Radiotherapy

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

PHASE2

This study is being conducted in patients with newly diagnosed breast cance...

Status

Completed

Location

Columbia University Irving Medical Center

Start Date

2012-10

Trial ID

NCT01847001

Treatments Being Tested

Propranolol DOT imaging Paclitaxel Nab-paclitaxel Trastuzumab Pertuzumab Doxorubicin Cyclophosphamide Surgery Premedication Anti-nausea therapy Pegfilgrastim

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

PHASE2

This phase II trial compares the effect of usual treatment of docetaxel che...

Status

Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-03-03

Trial ID

NCT05408845

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Docetaxel Echocardiography Test Magnetic Resonance Imaging Multigated Acquisition Scan Questionnaire Administration Trastuzumab Trastuzumab Deruxtecan Trastuzumab Emtansine

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

PHASE1

This is a study to compare the similarity in Pharmacokinetics (PK) profile ...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-07-03

Trial ID

NCT07601620

Treatments Being Tested

HLX319 EU-Phesgo®

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer

PHASE3

This study is a multicenter, randomized, open-label, parallel Phase III cli...

Status

Active Not Recruiting

Location

Shengjing Hospital, China Medical University

Start Date

2025-10-23

Trial ID

NCT07196774

Treatments Being Tested

SHR-A1811 for Injection Docetaxel injection Trastuzumab Injection Carboplatin for Injection Pertuzumab Injection

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

PHASE2

This phase II trial studies how well TPIV100 and sargramostim work in treat...

Status

Unknown

Location

Mayo Clinic in Arizona

Start Date

2020-02-20

Trial ID

NCT04197687

Treatments Being Tested

Multi-epitope HER2 Peptide Vaccine TPIV100 Pertuzumab Placebo Administration Sargramostim Trastuzumab Trastuzumab Emtansine

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

PHASE2

The purpose of the investigators study is to compare the efficacy and safet...

Status

Unknown

Location

Breast cancer institute of Fudan University Cancer Hospital

Start Date

2011-08

Trial ID

NCT01428414

Treatments Being Tested

Trastuzumab Paclitaxel Epirubicin Carboplatin

A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.

PHASE1

The main purpose of • To evaluate the safety, tolerability and pharmacokin...

Status

Completed

Location

Fudan University Shanghai Cancer Center

Start Date

2020-11-26

Trial ID

NCT05203601

Treatments Being Tested

SIBP-03

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

PHASE2

This is a randomized controlled trial of HER-2 positive breast cancer patie...

Status

Unknown

Location

PUMCH

Start Date

2017-03-01

Trial ID

NCT03085368

Treatments Being Tested

lapatinib/herceptin

Previous Next